{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:00:58Z","timestamp":1793530858916,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"India Ministry of Science &amp; Technology Department of Science and Technology","doi-asserted-by":"publisher","award":["IF200135"],"award-info":[{"award-number":["IF200135"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ICMR\/EMR\/2021\/10363"],"award-info":[{"award-number":["ICMR\/EMR\/2021\/10363"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117831","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:32:07Z","timestamp":1749555127000},"page":"117831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of caffeic acid-based novel multifunctional molecules for the management of Alzheimer's disease"],"prefix":"10.1016","volume":"296","author":[{"given":"Sunil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8003-5566","authenticated-orcid":false,"given":"Gyan","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117831_bib1","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/acs.jmedchem.4c03049","article-title":"Unlocking the therapeutic potential of natural products for alzheimer's disease","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib2","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","article-title":"Alzheimer's disease: exploring the landscape of cognitive decline","volume":"15","author":"Tenchov","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117831_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117309","article-title":"Design and synthesis three novel series of derivatives using natural acetylcholinesterase inhibitor-RLMS as template and in vitro, in vivo and in silico activities verification","volume":"286","author":"He","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib4","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1021\/acs.jmedchem.4c00159","article-title":"Discovery and optimization of tetrahydroisoquinoline derivatives to enhance lysosome biogenesis as preclinical candidates for the treatment of alzheimer's disease","volume":"67","author":"Zhou","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117199","article-title":"Progress in the study of anti-Alzheimer's disease activity of pyrimidine-containing bioactive molecules","volume":"285","author":"Liu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.117831_bib7","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1021\/jm701225u","article-title":"Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against alzheimer's disease","volume":"50","author":"Bolognesi","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib8","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.1021\/acs.jmedchem.4c00580","article-title":"Discovery of clinical candidate PF-06648671: a potent \u03b3-Secretase modulator for the treatment of Alzheimer's disease","volume":"67","author":"Pettersson","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117030","article-title":"Discovery of novel thiosemicarbazone-acridine targeting butyrylcholinesterase with antioxidant, metal complexing and neuroprotector abilities as potential treatment of alzheimer's disease: in vitro, in vivo, and in silico studies","volume":"281","author":"Silva Sousa","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib10","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s41401-020-00565-5","article-title":"New therapeutics beyond amyloid-\u03b2 and tau for the treatment of Alzheimer's disease","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117831_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117201","article-title":"Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BChE inhibitors, in-Vivo and in-Vitro assays, ADMET and molecular docking simulation","volume":"284","author":"Fayed","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer's disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.117831_bib13","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1021\/acs.jmedchem.6b00636","article-title":"Development of multifunctional pyrimidinylthiourea derivatives as potential anti-alzheimer agents","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib14","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1021\/acschemneuro.1c00184","article-title":"Phenothiazine-tacrine heterodimers: pursuing multitarget directed approach in Alzheimer's disease","volume":"12","author":"Gorecki","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117831_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117678","article-title":"Novel tacrine-based multi-target directed ligands: enhancing cholinesterase inhibition, NMDA receptor antagonism, and CNS bioavailability for Alzheimer's disease treatment","volume":"292","author":"Svobodova","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112257","article-title":"Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer's disease","volume":"198","author":"Singh","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117066","article-title":"Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer's disease","volume":"283","author":"Shankar","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib18","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1016\/j.bmcl.2012.08.036","article-title":"Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease","volume":"22","author":"Chao","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117831_bib19","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1021\/acschemneuro.1c00766","article-title":"Discovery of new 1,3,4-Oxadiazoles with dual activity targeting the cholinergic pathway as effective anti-alzheimer agents","volume":"13","author":"Elghazawy","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117831_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/jm049112h","article-title":"Rational approach to discover multipotent anti-alzheimer drugs","volume":"48","author":"Rosini","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116810","article-title":"Dual-target inhibitors based on acetylcholinesterase: novel agents for Alzheimer's disease","volume":"279","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117331","article-title":"Recent advances in the therapeutic insights of thiazole scaffolds as acetylcholinesterase inhibitors","volume":"287","author":"Dawood","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2019.02.021","article-title":"Novel tacrine-tryptophan hybrids: multi-target directed ligands as potential treatment for Alzheimer's disease","volume":"168","author":"Chalupova","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/13543776.2021.1874344","article-title":"Acetylcholinesterase inhibitors for the treatment of Alzheimer's disease - a patent review (2016-present)","volume":"31","author":"Bortolami","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.117831_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114606","article-title":"Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease","volume":"240","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib26","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acschemneuro.8b00391","article-title":"Reconsideration of anticholinesterase therapeutic strategies against alzheimer's disease","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117831_bib27","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1021\/jm401824w","article-title":"Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-alzheimer agents","volume":"57","author":"Viayna","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","article-title":"Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease","volume":"147","author":"Jiang","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.117831_bib29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cmdc.201600014","article-title":"Novel 8-Hydroxyquinoline derivatives as multitarget compounds for the treatment of Alzheimer's disease","volume":"11","author":"Prati","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117831_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117277","article-title":"Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer's disease","volume":"286","author":"Azam","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.drudis.2020.12.004","article-title":"Role of reactive oxygen species in the progression of Alzheimer's disease","volume":"26","author":"Bhatt","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117831_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112601","article-title":"The impact of chelating compounds on Cu2+, Fe2+\/3+, and Zn2+ ions in Alzheimer's disease treatment","volume":"257","author":"Mazur","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.117831_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bmc.2017.12.042","article-title":"A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease","volume":"26","author":"Zhang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib34","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1016\/j.bmc.2015.10.032","article-title":"Bivalent ligands incorporating curcumin and diosgenin as multifunctional compounds against Alzheimer's disease","volume":"23","author":"Chojnacki","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1021\/cn500081s","article-title":"Discovery of 5-(4-Hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-Methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for alzheimer's disease by hybridization of curcumin and Melatonin","volume":"5","author":"Chojnacki","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117831_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116385","article-title":"Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease","volume":"46","author":"Singh","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib37","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/cns.12286","article-title":"Effect of Tacrine-3-caffeic acid, A novel multifunctional anti-alzheimer's dimer, against oxidative-stress-induced cell death in HT22 hippocampal neurons: involvement of Nrf2\/HO-1 pathway","volume":"20","author":"Chao","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2025.117831_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2019.05.059","article-title":"Caffeic acid phenethyl ester (CAPE)-derivatives act as selective inhibitors of acetylcholinesterase","volume":"177","author":"Gie\u00dfel","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ejmech.2016.09.052","article-title":"Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease","volume":"125","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ph15060688","article-title":"Design, synthesis, and in vitro evaluation of novel 8-Amino-Quinoline combined with natural antioxidant acids","volume":"15","author":"Bacci","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117831_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejmech.2018.08.084","article-title":"Rationally designed divalent caffeic amides inhibit amyloid-\u03b2 fibrillization, induce fibril dissociation, and ameliorate cytotoxicity","volume":"158","author":"Tu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib42","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/14786419.2016.1219862","article-title":"Synthesis and evaluation of multifunctional ferulic and caffeic acid dimers for Alzheimer's disease","volume":"31","author":"He","year":"2017","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2025.117831_bib43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11947-023-03149-3","article-title":"Encapsulation of caffeic acid into sodium caseinate using pH-Driven method: fabrication, characterization, and bioavailability","volume":"17","author":"Chen","year":"2024","journal-title":"Food Bioprocess Technol."},{"key":"10.1016\/j.ejmech.2025.117831_bib44","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.molliq.2016.10.110","article-title":"Measurement and correlation of the solubility of caffeic acid in eight mono and water+ethanol mixed solvents at temperatures from (293.15 to 333.15) K","volume":"224","author":"Ji","year":"2016","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejmech.2025.117831_bib45","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1038\/s41598-022-07700-8","article-title":"The influence of the pH on the incorporation of caffeic acid into biomimetic membranes and cancer cells","volume":"12","author":"Naumowicz","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117831_bib46","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1021\/acs.jafc.9b02078","article-title":"Protective effect of caffeic acid against alzheimer's disease pathogenesis via modulating cerebral insulin signaling, \u03b2-Amyloid accumulation, and synaptic plasticity in hyperinsulinemic rats","volume":"67","author":"Chang","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib47","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/acschemneuro.3c00679","article-title":"Design, synthesis, and biological evaluation of ferulic acid template-based novel multifunctional ligands targeting NLRP3 inflammasome for the management of alzheimer's disease","volume":"15","author":"Singh","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117831_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12031-024-02232-4","article-title":"The possible neuroprotective effect of caffeic acid on cognitive changes and anxiety-like behavior occurring in young rats fed on high-fat diet and exposed to chronic stress: role of \u03b2-Catenin\/GSK-3B pathway","volume":"74","author":"El-Sayed","year":"2024","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117831_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115301","article-title":"Highly selective butyrylcholinesterase inhibitors related to amaryllidaceae alkaloids - design, synthesis, and biological evaluation","volume":"252","author":"Pidany","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-2797(99)00014-9","article-title":"Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase","volume":"119\u2013120","author":"Saxena","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.117831_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/5594386","article-title":"A comprehensive review of free radicals, oxidative stress, and antioxidants: overview, clinical applications, global perspectives, future directions, and mechanisms of antioxidant activity of flavonoid compounds","volume":"2024","author":"Tumilaar","year":"2024","journal-title":"J. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib53","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.3233\/JAD-240605","article-title":"Iron chelators and Alzheimer's disease clinical trials","volume":"100","author":"Mandal","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ejmech.2025.117831_bib54","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40263-024-01093-0","article-title":"Targeting biometals in Alzheimer's disease with metal chelating agents including coumarin derivatives","volume":"38","author":"Guck\u00fd","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2025.117831_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2021.126779","article-title":"Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: limitations, and current and future perspectives","volume":"67","author":"Fasae","year":"2021","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.ejmech.2025.117831_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116959","article-title":"Discovery of novel substituted (Z)-N\u2032-hydroxy-3-(3-phenylureido)benzimidamide derivatives as multifunctional molecules targeting pathological hallmarks of Alzheimer's disease","volume":"280","author":"Shankar","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib57","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117831_bib58","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.117831_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.ejmech.2025.117831_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1021\/acschemneuro.1c00443","article-title":"Exploration of neuroprotective properties of a naturally inspired multifunctional molecule (F24) against oxidative stress and amyloid \u03b2 induced neurotoxicity in Alzheimer's disease models","volume":"13","author":"Singh","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117831_bib61","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/jm401883v","article-title":"Structural modifications of neuroprotective anti-parkinsonian (\u2212)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule","volume":"57","author":"Modi","year":"2014","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:25:35Z","timestamp":1778513135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425005963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":61,"alternative-id":["S0223523425005963"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117831","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of caffeic acid-based novel multifunctional molecules for the management of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117831"}}